SOLEMPRI

Serial Number 98870885
Registration 7819051
700

Registration Progress

Application Filed
Nov 25, 2024
Under Examination
Approved for Publication
Apr 15, 2025
Published for Opposition
Apr 15, 2025
Registered
Jun 3, 2025

Basic Information

Serial Number
98870885
Registration Number
7819051
Filing Date
November 25, 2024
Registration Date
June 3, 2025
Published for Opposition
April 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 3, 2025
Registration
Registered
Classes
005

Rights Holder

Sun Pharmaceutical Industries Limited

16
Address
Western Express Highway, Goregaon (E)
Sun House, Plot No. 201 B/1
Mumbai, Maharashtra 400063
IN

Ownership History

Sun Pharmaceutical Industries Limited

Original Applicant
16
Mumbai, Maharashtra IN

Sun Pharmaceutical Industries Limited

Owner at Publication
16
Mumbai, Maharashtra IN

Sun Pharmaceutical Industries Limited

Original Registrant
16
Mumbai, Maharashtra IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Renewal Deadline
2156 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-03)
Due Date
June 03, 2031
Grace Period Ends
December 03, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description
Jun 3, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 PUBO A PUBLISHED FOR OPPOSITION
Apr 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 21, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2025 DOCK D ASSIGNED TO EXAMINER
Nov 25, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders; Pharmaceutical preparations for the treatment of cancer

Additional Information

Translation
The wording SOLEMPRI has no meaning in a foreign language.

Classification

International Classes
005